Literature DB >> 1672325

Postoperative infections in breast surgery.

J Chen1, Z Gutkin, J Bawnik.   

Abstract

The rate of infections in mastectomy wounds is apparently higher than normally allowed for in clean operations. A retrospective analysis of our results over two time periods shows a 6.4% infection rate for a one-step operation and 11.1% for a two-step operation between 1970 and 1976, compared with 2.6% and 7.6% for 1980-86, respectively. In accordance with other published reports, we found that a two-step operation, and advanced age, increase the danger of infection. The predominant pathogens were staphylococci. We advise the employment of a one-step operation in conjunction with prophylactic use of antibiotics.

Entities:  

Mesh:

Year:  1991        PMID: 1672325     DOI: 10.1016/0195-6701(91)90078-m

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  THE EPIDEMIOLOGY AND OUTCOMES OF BREAST CANCER SURGERY.

Authors:  Victoria J Fraser; Katelin B Nickel; Ida K Fox; Julie A Margenthaler; Margaret A Olsen
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

2.  Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care.

Authors:  Mahmoud B El-Tamer; B Marie Ward; Tracy Schifftner; Leigh Neumayer; Shukri Khuri; William Henderson
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

3.  Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon; Mauricio Tawil; Lilian Torregrosa
Journal:  BMC Surg       Date:  2012-08-31       Impact factor: 2.102

4.  Dressing wear time after breast reconstruction: study protocol for a randomized controlled trial.

Authors:  Daniela Francescato Veiga; Joel Veiga-Filho; Carlos Américo Veiga Damasceno; Edilaine Maria Leci Sales; Thiago Bezerra Morais; Wânia Eliza Almeida; Neil Ferreira Novo; Lydia Masako Ferreira
Journal:  Trials       Date:  2013-02-22       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.